ES8605769A1 - Un procedimiento para la preparacion de un peptido - Google Patents

Un procedimiento para la preparacion de un peptido

Info

Publication number
ES8605769A1
ES8605769A1 ES542212A ES542212A ES8605769A1 ES 8605769 A1 ES8605769 A1 ES 8605769A1 ES 542212 A ES542212 A ES 542212A ES 542212 A ES542212 A ES 542212A ES 8605769 A1 ES8605769 A1 ES 8605769A1
Authority
ES
Spain
Prior art keywords
peptides
image
leu
lys
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES542212A
Other languages
English (en)
Other versions
ES542212A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of ES8605769A1 publication Critical patent/ES8605769A1/es
Publication of ES542212A0 publication Critical patent/ES542212A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/16Oxytocins; Vasopressins; Related peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1021Tetrapeptides with the first amino acid being acidic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/15Oxytocin or vasopressin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE UN PEPTIDO Y DE SUS DERIVADOS FUNCIONALES, DE FORMULA (I), EN LA QUE A REPRESENTA ARG, LIS, O LEU Y R REPRESENTA EL GRUPO HL-CIS-OH O H-L-ASX-L-CIS-L-PRO-L-A-OH. CONSISTE EN LA ELIMINACION DE LOS GRUPOS PROTECTORES O EL VEHICULO EN FASE SOLIDA EN EL PEPTIDO DE FORMULA (II), EN LA QUE R TIENE EL MISMO SIGNIFICADO QUE EN LA FORMULA (I) Y B, Q Y A PUEDEN SER VARIOS TIPOS DE RADICALES, Y EN EL QUE SI Q NO REPRESENTA UN VEHICULO EN FASE SOLIDA, HAY AL MENOS UN GRUPO PROTECTOR. LA ELIMINACION DE LOS GRUPOS PROTECTORES SE EFECTUA SIGUIENDO METODOS CONVENCIONALES EN CADA CASO, Y LA SEPARACION DEL VEHICULO SE PUEDE HACER CON ACIDO TRIFLUORMETANOSULFONICO. ESTOS PEPTIDOS TIENEN APLICACIONES FARMACOLOGICAS POR SU INFLUENCIA SOBRE LOS PROCESOS DE LA MEMORIA.
ES542212A 1984-04-13 1985-04-12 Un procedimiento para la preparacion de un peptido Granted ES542212A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8401187 1984-04-13

Publications (2)

Publication Number Publication Date
ES8605769A1 true ES8605769A1 (es) 1985-12-16
ES542212A0 ES542212A0 (es) 1985-12-16

Family

ID=19843805

Family Applications (1)

Application Number Title Priority Date Filing Date
ES542212A Granted ES542212A0 (es) 1984-04-13 1985-04-12 Un procedimiento para la preparacion de un peptido

Country Status (13)

Country Link
US (1) US4623640A (es)
EP (1) EP0161017B1 (es)
JP (1) JPS60231697A (es)
KR (1) KR870001145B1 (es)
AU (1) AU574154B2 (es)
CA (1) CA1250400A (es)
DE (1) DE3560261D1 (es)
DK (1) DK166154C (es)
ES (1) ES542212A0 (es)
FI (1) FI85275C (es)
HU (1) HU192206B (es)
IE (1) IE58407B1 (es)
ZA (1) ZA852535B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1238314A (en) * 1983-09-22 1988-06-21 James F. Callahan Process for preparing basic heptapeptide vasopressin antagonists
US4748154A (en) * 1985-12-24 1988-05-31 Takeda Chemical Industries, Ltd. Peptide derivatives, their production and use
JP2542241B2 (ja) * 1988-08-12 1996-10-09 富士レビオ株式会社 ペプチド
ATE113606T1 (de) * 1989-04-15 1994-11-15 Nippon Chemiphar Co Peptide und diese peptide enthaltende wirkstoffe gegen dementia.
DK53191D0 (da) * 1991-03-25 1991-03-25 Carlbiotech Ltd As Organosvovlforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
GB2269821B (en) * 1992-08-08 1996-06-05 Shanghai Inst Biochemistry Memory enhancing peptides and pharmaceutical compositions containing them
CN1154656C (zh) * 2000-06-30 2004-06-23 上海中科英泰生物技术有限公司 一类记忆增强肽和它们的用途
US7402157B2 (en) * 2001-12-19 2008-07-22 The Procter & Gamble Company Absorbent article having perception of depth

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS171787B1 (es) * 1973-11-09 1976-11-29
IE56021B1 (en) * 1982-10-13 1991-03-27 Akzo Nv Peptides

Also Published As

Publication number Publication date
EP0161017A1 (en) 1985-11-13
IE58407B1 (en) 1993-09-22
HUT37804A (en) 1986-02-28
FI85275C (fi) 1992-03-25
US4623640A (en) 1986-11-18
DE3560261D1 (en) 1987-07-23
EP0161017B1 (en) 1987-06-16
KR870001145B1 (ko) 1987-06-11
DK166154C (da) 1993-08-09
IE850829L (en) 1985-10-13
DK166154B (da) 1993-03-15
AU4101285A (en) 1985-10-17
FI85275B (fi) 1991-12-13
ZA852535B (en) 1985-11-27
AU574154B2 (en) 1988-06-30
FI851488L (fi) 1985-10-14
CA1250400A (en) 1989-02-21
DK165885A (da) 1985-10-14
KR850007802A (ko) 1985-12-09
DK165885D0 (da) 1985-04-12
JPS60231697A (ja) 1985-11-18
HU192206B (en) 1987-05-28
ES542212A0 (es) 1985-12-16
FI851488A0 (fi) 1985-04-12

Similar Documents

Publication Publication Date Title
ES8501364A1 (es) Un metodo para la preparacion de nuevos polipeptidos.
JO2034B1 (en) Isotopes of the hormone peptide its uses and the chemical compounds it contains
AU571225B2 (en) Retro-inverso analogues of the bradykinin potentiating peptide bpp 5a
DE3169160D1 (en) Amino-acids derivatives and their therapeutic use
CA2110693A1 (en) Amino acid derivative anticonvulsant
MX9500072A (es) Compuestos con propiedades de liberacion de la hormona del crecimiento.
DK0728148T3 (da) Forbedrede immunogene sammensætninger mod humant gastrin 17
GR3034924T3 (en) Novel peptide derivatives
EP0254080A3 (en) Malonic acid derivatives and methods for their synthesis
GR3033661T3 (en) Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo(c)azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace
EP0662516A4 (en) NEW ELAFINE DERIVATIVE.
ES8706654A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazina
ES8605769A1 (es) Un procedimiento para la preparacion de un peptido
CA2020838A1 (en) Hemoregulatory peptides
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
GR852541B (es)
ES8304919A1 (es) Un procedimiento para la preparacion de dicloroamino-acidos.
NZ279396A (en) Octahydro-6-hetring[2,1-a][2]benzazepine disulphide derivatives
GB9324931D0 (en) Glutaramide derivatives
IL80804A (en) Process for the preparation of peptides by use of perchlorates
MY106274A (en) Sdk peptides, a preparation process of the same and therapeutic compositions containing them.
DE3855751D1 (en) Hypoglycemische peptide
AP9400608A0 (en) "New nicotinic acid derivative".
EP1840134A3 (en) GLP-1 derivatives
UA16247A1 (uk) N-(3-ХЛОРО-1,4-HАФТОХІHОHІЛ-2)-2-Д, alРha-АСПАРАГІHОВУ КИСЛОТА, ЩО ПРОЯВЛЯЄ КАРДІОСТИМУЛЮЮЧІ ВЛАСТИВОСТІ

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519